Federal contract award
AIDOAATO1500007
IGF::CL::IGF - GHSC IDIQ - HIV/AIDS TO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Agency for International Development |
| Office | USAID M/OAA |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R425 — Engineering and Technical Services |
| Parent award / vehicle | AIDOAAI1500004 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.7B |
| Current contract value | $7.6B |
| Potential contract value / ceiling | $7.6B |
| Start date | Apr 20, 2015 |
| Current end date | Nov 28, 2026 |
| Potential end date | Nov 28, 2026 |
| Latest award activity | Aug 28, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 127 of 127 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2025 | 126 | $326.4M | GHSC - CHEMONICS - PSM TO1 |
| May 8, 2025 | 125 | $40.0M | GHSC - CHEMONICS - PSM TO1 |
| Jan 17, 2025 | 124 | $20.9M | GHSC - CHEMONICS - PSM TO1 |
| Jan 15, 2025 | 123 | $0 | GHSC - CHEMONICS - PSM TO1 |
| Dec 18, 2024 | 122 | $163.8M | GHSC - CHEMONICS - PSM TO1 |
| Sep 17, 2024 | 121 | $211.9M | GHSC - CHEMONICS - PSM TO1 |
| Aug 14, 2024 | 120 | $3.7M | GHSC - CHEMONICS - PSM TO1 |
| Jul 22, 2024 | 119 | $207.0M | GHSC - CHEMONICS - PSM TO1 |
| Jul 9, 2024 | 118 | $-3.8M | GHSC - CHEMONICS - PSM TO1 |
| Jun 12, 2024 | 117 | $0 | GHSC - CHEMONICS - PSM TO1 |
| May 13, 2024 | 116 | $29.0M | GHSC - CHEMONICS - PSM TO1 |
| Mar 22, 2024 | 115 | $4.9M | GHSC - CHEMONICS - PSM TO1 |
| Feb 22, 2024 | 114 | $107.0M | GHSC - CHEMONICS - PSM TO1 |
| Nov 30, 2023 | 113 | $147.0M | GHSC - CHEMONICS - PSM TO1 |
| Sep 28, 2023 | 112 | $65.3M | GHSC - CHEMONICS - PSM TO1 |
| Aug 30, 2023 | 111 | $5.5M | GHSC - CHEMONICS - PSM TO1 |
| Jul 21, 2023 | 110 | $691.3K | GHSC - CHEMONICS - PSM TO1 |
| Jun 1, 2023 | 109 | $4.3M | GHSC - CHEMONICS - PSM TO1 |
| May 19, 2023 | 108 | $2.8M | GHSC - CHEMONICS - PSM TO1 |
| May 15, 2023 | 107 | $-11.2M | GHSC - CHEMONICS - PSM TO1 |
| Apr 6, 2023 | 106 | $27.6M | GHSC - CHEMONICS - PSM TO1 |
| Feb 16, 2023 | 105 | $39.8M | GHSC - CHEMONICS - PSM TO1 |
| Dec 21, 2022 | 104 | $300.7M | GHSC - CHEMONICS - PSM TO1 |
| Nov 3, 2022 | 103 | $0 | GHSC - CHEMONICS - PSM TO1 |
| Sep 29, 2022 | 102 | $450.0K | GHSC - CHEMONICS - PSM TO1 |
| Sep 22, 2022 | 101 | $672.5K | GHSC - CHEMONICS - PSM TO1 |
| Sep 16, 2022 | 100 | $-672.5K | GHSC - CHEMONICS - PSM TO1 |
| Sep 13, 2022 | 99 | $237.9M | GHSC - CHEMONICS - PSM TO1 |
| Aug 1, 2022 | 98 | $556.7K | GHSC - CHEMONICS - PSM TO1 |
| Jul 21, 2022 | 97 | $6.7M | GHSC - CHEMONICS - PSM TO1 |
| Jul 19, 2022 | 96 | $0 | GHSC - CHEMONICS - PSM TO1 |
| Jul 7, 2022 | 95 | $6.3M | GHSC - CHEMONICS - PSM TO1 |
| Jun 10, 2022 | 94 | $8.1M | GHSC - CHEMONICS - PSM TO1 |
| May 27, 2022 | 93 | $3.8M | GHSC - CHEMONICS - PSM TO1 |
| May 20, 2022 | 92 | $1.3M | GHSC - CHEMONICS - PSM TO1 |
| May 10, 2022 | 91 | $11.7M | GHSC - CHEMONICS - PSM TO1 |
| Apr 25, 2022 | 90 | $6.6M | GHSC - CHEMONICS - PSM TO1 |
| Apr 15, 2022 | 89 | $12.1M | GHSC - CHEMONICS - PSM TO1 |
| Apr 4, 2022 | 88 | $2.0M | GHSC - CHEMONICS - PSM TO1 |
| Mar 11, 2022 | 87 | $3.2M | GHSC - CHEMONICS - PSM TO1 |
| Feb 24, 2022 | 86 | $31.9M | GHSC - CHEMONICS - PSM TO1 |
| Jan 25, 2022 | 85 | $-650.0K | GHSC - CHEMONICS - PSM TO1 |
| Jan 6, 2022 | 84 | $1.4M | GHSC - CHEMONICS - PSM TO1 |
| Dec 21, 2021 | 83 | $218.7K | GHSC - CHEMONICS - PSM TO1 |
| Dec 15, 2021 | 82 | $4.9M | GHSC - CHEMONICS - PSM TO1 |
| Dec 3, 2021 | 81 | $18.3M | GHSC - CHEMONICS - PSM TO1 |
| Nov 18, 2021 | 80 | $291.0M | GHSC - CHEMONICS - PSM TO1 |
| Nov 8, 2021 | 79 | $12.0M | GHSC - CHEMONICS - PSM TO1 |
| Oct 15, 2021 | 78 | $18.0M | GHSC - CHEMONICS - PSM TO1 |
| Sep 29, 2021 | 77 | $271.9M | GHSC - CHEMONICS - PSM TO1 |
| Sep 21, 2021 | 76 | $30.5M | GHSC - CHEMONICS - PSM TO1 |
| Sep 14, 2021 | 75 | $2.8M | GHSC - CHEMONICS - PSM TO1 |
| Sep 13, 2021 | 74 | $-75.2K | GHSC - CHEMONICS - PSM TO1 |
| Aug 31, 2021 | 73 | $10.7M | GHSC - CHEMONICS - PSM TO1 |
| Aug 30, 2021 | 72 | $18.4M | GHSC - CHEMONICS - PSM TO1 |
| Aug 19, 2021 | 71 | $17.5M | GHSC - CHEMONICS - PSM TO1 |
| Aug 16, 2021 | 70 | $-250.5K | GHSC - CHEMONICS - PSM TO1 |
| Aug 6, 2021 | 69 | $7.5M | GHSC - CHEMONICS - PSM TO1 |
| Aug 2, 2021 | 68 | $29.6M | GHSC - CHEMONICS - PSM TO1 |
| Jul 16, 2021 | 67 | $9.0M | GHSC - CHEMONICS - PSM TO1 |
| Jun 17, 2021 | 66 | $15.8M | GHSC - CHEMONICS - PSM TO1 |
| May 28, 2021 | 65 | $3.5M | GHSC - CHEMONICS - PSM TO1 |
| Apr 21, 2021 | 64 | $16.8M | GHSC - CHEMONICS - PSM TO1 |
| Mar 31, 2021 | 63 | $6.1M | GHSC - CHEMONICS - PSM TO1 |
| Feb 12, 2021 | 62 | $1.5M | GHSC - CHEMONICS - PSM TO1 |
| Jan 26, 2021 | 61 | $2.0M | GHSC - PSM TO1 |
| Jan 14, 2021 | 60 | $358.2M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Dec 4, 2020 | 59 | $50.6M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Oct 28, 2020 | 58 | $8.1M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Sep 30, 2020 | 57 | $276.8M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Sep 21, 2020 | 56 | $4.8M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Aug 27, 2020 | 54 | $5.6M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Aug 27, 2020 | 55 | $774.9K | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Aug 26, 2020 | 53 | $-200.0K | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Aug 20, 2020 | 52 | $0 | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Aug 4, 2020 | 51 | $1.5M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jul 30, 2020 | 50 | $6.5M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jul 28, 2020 | 49 | $-14.0M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jul 10, 2020 | 48 | $1.4M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jul 2, 2020 | 47 | $2.0M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 29, 2020 | 46 | $1.3M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 26, 2020 | 44 | $4.5M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 26, 2020 | 45 | $11.9M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 22, 2020 | 43 | $23.5M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 19, 2020 | 41 | $98.1M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 19, 2020 | 42 | $563.1K | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 10, 2020 | 40 | $4.2M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jun 7, 2020 | 39 | $21.5M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| May 19, 2020 | 38 | $5.9M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| May 15, 2020 | 36 | $0 | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| May 15, 2020 | 37 | $7.0M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| May 14, 2020 | 35 | $27.6M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Apr 24, 2020 | 34 | $-1.8M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Apr 21, 2020 | 33 | $174.2M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Apr 2, 2020 | 32 | $26.2M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Feb 18, 2020 | 31 | $350.1M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jan 15, 2020 | 29 | $0 | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Jan 15, 2020 | 30 | $202.4M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Dec 11, 2019 | 28 | $50.3M | GHSC-PSM - CHEMONICS - HIV/AIDS TO1 |
| Nov 25, 2019 | 27 | $46.6M | GHSC-PSM - HIV/AIDS TO1 |
| Sep 30, 2019 | 26 | $592.8K | GHSC-PSM - HIV/AIDS TO1 |
| Sep 19, 2019 | 25 | $0 | GHSC-PSM - HIV/AIDS TO1 |
| Sep 6, 2019 | 24 | $232.0M | GHSC-PSM - HIV/AIDS TO1 |
| Aug 20, 2019 | 23 | $257.9K | GHSC-PSM - HIV/AIDS TO1 |
| Jun 27, 2019 | 22 | $29.2M | GHSC-PSM - HIV/AIDS TO1 |
| Jun 14, 2019 | 21 | $0 | GHSC-PSM - HIV/AIDS TO1 |
| May 29, 2019 | 20 | $936.4K | GHSC-PSM - HIV/AIDS TO1 |
| Apr 23, 2019 | 19 | $10.3M | GHSC-PSM - HIV/AIDS TO1 |
| Apr 12, 2019 | 18 | $108.0M | GHSC-PSM - HIV/AIDS TO1 |
| Feb 14, 2019 | 17 | $29.8M | GHSC-PSM - HIV/AIDS TO1 |
| Dec 21, 2018 | 16 | $202.5M | GHSC-PSM - HIV/AIDS TO1 |
| Sep 13, 2018 | 15 | $100.0K | GHSC-PSM - HIV/AIDS TO1 |
| Aug 30, 2018 | 14 | $198.2K | GHSC-PSM - HIV/AIDS TO1 |
| Aug 15, 2018 | 13 | $25.0M | GHSC-PSM - HIV/AIDS TO1 |
| Aug 10, 2018 | 12 | $22.5M | GHSC-PSM - HIV/AIDS TO1 |
| Jun 6, 2018 | 11 | $655.2K | GHSC-PSM - HIV/AIDS TO1 |
| May 21, 2018 | 10 | $303.0M | GHSC-PSM - HIV/AIDS TO1 |
| May 4, 2018 | 9 | $-610.0K | GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Feb 26, 2018 | 8 | $229.9M | GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Sep 14, 2017 | 7 | $4.4M | IGF::CT::IGF GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Aug 10, 2017 | 6 | $21.4M | IGF::CT::IGF GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| May 18, 2017 | 5 | $403.8M | IGF::CT::IGF GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Mar 10, 2017 | 4 | $303.6M | IGF::CT::IGF GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Sep 21, 2016 | 3 | $173.4M | IGF::CT::IGF - GHSC-PSM - HIV/AIDS TASK ORDER #1 |
| Feb 5, 2016 | 2 | $50.0M | IGF::CT::IGF GHSC IDIQ - HIV/AIDS TASK ORDER |
| Aug 27, 2015 | 1 | $0 | IGF::CL::IGF - GHSC IDIQ - HIV/AIDS TO |
| Apr 17, 2015 | 0 | $2.5M | IGF::CL::IGF - GHSC IDIQ - HIV/AIDS TO |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2026-11-28 (34 days from calculation)
- +35 points
- 50 historical awards in this buyer and category group
- +15 points
- 127 recorded award transactions
- +10 points
- Latest award action: 2025-08-28
- +0 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.